Dr. Sayed A. Tabatabai, MD

Dr. Tabatabai practices at Pulse Physician Organization in Huntsville, Texas.

Dr. Tabatabai's NPI, 1265552145, was assigned on April 2, 2007. Dr. Tabatabai graduated from Albany Medical College in 2004. Dr. Tabatabai holds Texas license Q4310.

Dr. Tabatabai's primary practice is Pulse Physician Organization, at 119 Medical Park Ln Ste D, Huntsville, TX 77340. The practice phone is (936) 277-1000.

Dr. Tabatabai's primary practice is Pulse Physician Organization in Huntsville, Texas. Dr. Tabatabai is also affiliated with Huntsville Memorial Hospital. The medical group on file is Pulse Healthcare System. Dmand AI also links Dr. Tabatabai to 2 more hospitals, 3 group practices and clinics, 2 dialysis centers and 2 medical groups, each named with a free account. Dr. Tabatabai's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabatabai practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Tabatabai's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Tabatabai is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tabatabai's licenses on file in 3 states: Texas, New York and Maryland.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and kidney disease among the conditions Dr. Tabatabai treats.

CMS data shows 3,014 Medicare services from Dr. Tabatabai across 13 procedure codes in 2024, for 870 Medicare patients. Medicare paid $297,491 for them.

CMS counts 870 Medicare patients who saw Dr. Tabatabai in 2024. The largest group is 75 to 84, with 359 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tabatabai's median patient age at 71, with 53% women.

In 2024, Dr. Tabatabai wrote 1,626 Medicare Part D claims for 337 patients. 84% of them were for generic drugs. CMS names the drug for 1,399 of them, across 36 drugs with 11 or more claims each, at $506,022 in total drug cost. In 2023, CMS named 1,192 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Tabatabai for performance year 2024, reported as part of a group. Dr. Tabatabai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Tabatabai, published from 2009 to 2014. The most frequent topics are Kidney Diseases. Dr. Tabatabai's most frequent co-authors are Mohamed G. Atta, MD, Essam F. Elsayed, MD and Derek Michael Fine, MD.

CMS Open Payments shows 421 general payments to Dr. Tabatabai from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $1,930.

Dmand AI lists 1 award for Dr. Tabatabai, most recently CMS Stage 1 2012 in 2012.

Dr. Tabatabai graduated from Albany Medical College in 2004.

Dr. Tabatabai is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.